References
- Stewart RD, Li XA. BGRT: biologically guided radiation therapy – the future is fast approaching! Med. Phys.34, 3739–2751 (2007)
- Scarantino CW, Rini CJ, Aquino M et al. Initial clinical results of an in vivo dosimeter during external beam radiation therapy. Int. J. Radiat. Oncol. Biol. Phys.62, 606–613 (2005)
- Black RD, Scarantino CW, Mann GG et al. An analysis of an implantable dosimeter system for external beam therapy. Int. J. Radiat. Oncol. Biol. Phys.63, 290–300 (2005).
- Hayne D, Johnson U, D’Souza D et al. Anorectal irradiation in pelvic radiotherapy: an assessment using in-vivo dosimetry. Clin. Oncol. (R. Coll. Radiol.)13, 126–129 (2001).
- Weber DC, Nouet P, Kurtz JM et al. Assessment of target dose delivery in anal cancer using in vivo thermoluminescent dosimetry. Radiother. Oncol.59, 39–43 (2001).
- Wertz H, Boda-Heggemann J, Walter C et al. Image guided in vivo dosimetry for quality assurance of IMRT treatment for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys.67, 288–295 (2007).
- Chuang CF, Verhey LJ, Xia P. Investigation of the use of MOSFET for clinical IMRT dosimetric verification. Med. Phys.29, 1109–1115 (2002)
- Halvorsen P. Dosimetric evaluation of a new design MOSFET in vivo dosimeter. Med. Phys.32(1), 110–117 (2002).
- Beddar AS, Salehpour M, Briere TM et al. Preliminary evaluation of implantable MOSFET radiation dosimeters. Phys. Med. Biol.50, 141–149 (2005).
- Scarantino CW, Ruslander DM, Rini CJ et al. An implantable radiation dosimeter for use in external beam radiation therapy. Med. Phys.31, 2658–2671 (2004).
- Beyer GP, Mann G, Pursley J et al. An implantable MOSFET dosimeter for the measurement of radiation dose in tissue during cancer therapy. IEEE Sensors J.8(1), 38–51 (2008).
- Briere TM, Beddar AS, Gillin MT. Evaluation of precalibrated implantable MOSFET radiation dosimeters for megavoltage photon beams. Med. Phys.32, 3346–3349 (2005).
- Briere TM, Gillin MT, Beddar AS. Implantable MOSFET detectors: evaluation of a new design. Med. Phys.34(12), 4585–4590 (2007).
- Beyer GP, Scarantino CW, Prestidge BR et al. Technical evaluation of radiation dose delivered in prostate patients as measured by an implantable MOSFET dosimeter. Int. J. Radiat. Oncol. Biol. Phys.69, 925–935 (2007).
- Shukovsky LJ. Dose, time, volume relationships in squamous cell carcinoma of the supraglottic larynx. Am. J. Roent. Rad. Ther. Nucl. Med.108, 27–29 (1970).
- Kaplan HS. Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin’s disease. Cancer Res.26, 1221–1224 (1966).
- Hellman S. Improving the therapeutic index in breast cancer treatment. Cancer Res.40, 4335–4342 (1980).
- Eade TN, Hanlon AL, Horwitz EM et al. What dose of external-beam radiation is high enough for prostate cancer? Int. J. Radiat. Oncol. Biol. Phys.68, 682–689 (2007).
- Kupelian P, Willoughby T, Mahadevan A et al. Multi-institutional clinical experience with the Calypso system in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.67, 1088–1098 (2007).
- Litzenberg DW, Balter JM, Hadley SW et al. Influence of intrafraction motion on margins for prostate radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.65, 528–534 (2006).
- Langen KM, Zhang Y, Andrews RD et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. Int. J. Radiat. Oncol. Biol. Phys.62, 1517–1524 (2005).
- Yue NJ, Li X, Beriwal S et al. The intrafraction motion induced dosimetric impacts in breast 3D radiation treatment: a 4DCT based study. Med. Phys.34, 2789–2800 (2007).